<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="amrf" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">amrf</book-part-id>
      <title-group>
        <title>Action Myoclonus &#x02013; Renal Failure Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Amrom</surname>
            <given-names>Dina</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Neurogenetics Unit<break/>Montreal Neurological Hospital &#x00026; Institute<break/>Department of Neurology &#x00026; Neurosurgery<break/>McGill University<break/>Montreal, Quebec, Canada</aff>
          <email>dina.amrom@mail.mcgill.ca</email>
          <email>dina.amrom@ulb.ac.be</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Andermann</surname>
            <given-names>Frederick</given-names>
          </name>
          <degrees>MD, FRCP(C)</degrees>
          <aff>Epilepsy Research Group<break/>Montreal Neurological Hospital &#x00026; Institute<break/>Departments of Neurology &#x00026; Neurosurgery and Pediatrics<break/>McGill University<break/>Montreal, Quebec, Canada</aff>
          <email>frederick.andermann@mcgill.ca</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Andermann</surname>
            <given-names>Eva</given-names>
          </name>
          <degrees>MDCM, PhD, FCCMG</degrees>
          <aff>Neurogenetics Unit and Epilepsy Research Group<break/>Montreal Neurological Hospital &#x00026; Institute<break/>Departments of Neurology &#x00026; Neurosurgery and Human Genetics<break/>McGill University<break/>Montreal, Quebec, Canada</aff>
          <email>eva.andermann@mcgill.ca</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>17</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="npab" document-type="chapter">Acid Sphingomyelinase Deficiency</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="aip" document-type="chapter">Acute Intermittent Porphyria</related-object>
      <abstract id="amrf.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical description</title>
          <p>Action myoclonus &#x02013; renal failure (AMRF) syndrome typically comprises a continuum of two major (and ultimately fatal) manifestations: progressive myoclonic epilepsy (PME) and renal failure; however, in some instances, the kidneys are not involved. Neurologic manifestations can appear before, simultaneously, or after the renal manifestations. Disease manifestations are usually evident in the late teens or early twenties. In the rare instances in which renal manifestations precede neurologic findings, onset is usually in late childhood/early adolescence but can range to the fifth or sixth decade. Neurologic manifestations begin with tremor at rest (which is exacerbated by fine motor activities) and progress to involuntary, action-activated myoclonic jerks that involve bulbar, proximal, and distal limb muscles; involuntary spontaneous myoclonic jerks; and generalized clonic-tonic-clonic seizures. Sensorimotor peripheral neuropathy and sensorineural hearing loss can also be observed. Renal manifestations include proteinuria that can progress to nephrotic syndrome and end-stage renal disease.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of AMRF syndrome is suspected in a previously healthy teenager or young adult with the characteristic neurologic and/or renal manifestations. The diagnosis is confirmed in individuals with biallelic (homozygous or compound heterozygous) loss-of-function pathogenic variants in <italic toggle="yes">SCARB2.</italic></p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Symptomatic pharmacologic and psychosocial support is the mainstay of care for the neurologic manifestations. Response to treatment is variable and may worsen over time, necessitating rehabilitative management. Renal insufficiency requires dialysis but response to treatment is poor, and renal transplantation is often necessary.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Standard measures for prevention of aspiration pneumonia and sudden unexpected death in epilepsy should be followed.</p>
          <p><italic toggle="yes">Surveillance:</italic> Lifelong follow up should include regular monitoring of antiepileptic drug treatment and renal function (including urinary protein excretion, creatinine clearance, and estimated glomerular filtration rate) and periodic assessment of hearing and peripheral nerves<italic toggle="yes">.</italic></p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Diphenylhydantoin, carbamazepine, oxcarbazepine, and possibly lamotrigine increase myoclonus and should be avoided in any individual with PME.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Because some antiepileptic drugs can lead to an increased risk of malformations, growth retardation, or neurodevelopmental disabilities in exposed fetuses, standard measures for prevention of fetopathy should be followed.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>AMRF syndrome is inherited in an autosomal recessive manner. At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk require prior identification of the <italic toggle="yes">SCARB2</italic> pathogenic variants in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="amrf.Diagnosis">
        <title>Diagnosis</title>
        <sec id="amrf.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Action myoclonus &#x02013; renal failure (AMRF) syndrome is suspected in a previously healthy teenager or young adult with the following neurologic and renal manifestations [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.vadlamudi.2006.1310">Vadlamudi et al 2006</xref>, <xref ref-type="bibr" rid="amrf.REF.andermann.2011">Andermann 2011</xref>]:</p>
          <p>
            <bold>Neurologic manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A fine tremor of the fingers and hands, present at rest, exacerbated by fine motor activities such as writing and relieved by alcohol or propranolol, is commonly the first finding. The tremor can later involve the head, trunk, lower extremities, and sometimes tongue and voice. In the later stages of the disease, it becomes masked by striking myoclonic jerks.</p>
            </list-item>
            <list-item>
              <p>Involuntary, action-activated myoclonic jerks, also induced by attempted and executed speech, involve bulbar as well as proximal and distal limb muscles. The myoclonus is reflex-sensitive to touch on the distal extremities.</p>
            </list-item>
            <list-item>
              <p>Involuntary spontaneous myoclonic jerks of the face (particularly perioral) as well as synchronous and asynchronous jerks of the trunk and limbs also occur at rest.</p>
            </list-item>
            <list-item>
              <p>Generalized clonic-tonic-clonic seizures, diurnal and/or nocturnal, start with a generalized clonic phase with preserved consciousness and proceed to unconsciousness with tonic-clonic features and urinary incontinence.</p>
            </list-item>
            <list-item>
              <p>Other findings can include sensorimotor peripheral neuropathy (most often predominantly demyelinating or more rarely axonal) and sensorineural hearing loss (SNHL).</p>
            </list-item>
          </list>
          <p>
            <bold>Renal manifestations</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Proteinuria, the first manifestation of renal disease, is initially mild and asymptomatic.</p>
            </list-item>
            <list-item>
              <p>Renal disease can progress to nephrotic syndrome and end-stage renal disease.</p>
            </list-item>
            <list-item>
              <p>In some families, renal manifestations (eventually requiring renal transplantation) appear first in late childhood or early teens and neurologic manifestations in the late twenties or early thirties [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>Histologic changes include interstitial fibrosis, atrophy, focal sclerosing glomerulonephritis sometimes with features of collapsing glomerulopathy (a severe variant of glomerulosclerosis), or membranous nephropathy. No storage was observed [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.berkovic.2008.673">Berkovic et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>Note: Immunostaining can show IgM and complement present in the glomerular loops and in the mesangium [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>]. In one patient, a C1q nephropathy has been shown by immunohistochemistry [<xref ref-type="bibr" rid="amrf.REF.balreira.2008.2238">Balreira et al 2008</xref>, <xref ref-type="bibr" rid="amrf.REF.chaves.2011.738">Chaves et al 2011</xref>], indicating an immune complex-mediated glomerular disease. In this patient, extensive tubular abnormalities were also present, as well as granular material in cortical tubules. No Gaucher cells were observed.</p>
            </list-item>
          </list>
          <p>A classification that takes into account the age at disease onset and the clinical manifestations has been proposed (<xref ref-type="table" rid="amrf.T.clinical_manifestations_of_amrf">Table 2</xref>).</p>
        </sec>
        <sec id="amrf.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of action myoclonus &#x02013; renal failure (AMRF) syndrome is confirmed in individuals with biallelic (homozygous or compound heterozygous) loss-of-function pathogenic variants in <italic toggle="yes">SCARB2</italic> [<xref ref-type="bibr" rid="amrf.REF.balreira.2008.2238">Balreira et al 2008</xref>, <xref ref-type="bibr" rid="amrf.REF.berkovic.2008.673">Berkovic et al 2008</xref>] (<xref ref-type="table" rid="amrf.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          <p>Note: Molecular diagnosis performed early in the disease course may eliminate the need for numerous invasive neurologic and renal investigations.</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>.</p>
          <p>
            <bold>Single-gene testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Persons of French-Canadian ancestry.</bold> It is appropriate to start with targeted analysis of the two most common pathogenic variants in that population: c.862C&#x0003e;T [<xref ref-type="bibr" rid="amrf.REF.berkovic.2008.673">Berkovic et al 2008</xref>] and c.1187+3insT [<xref ref-type="bibr" rid="amrf.REF.dibbens.2011.812">Dibbens et al 2011</xref>]. If no or only one pathogenic variant is found, it is appropriate to perform sequence analysis of <italic toggle="yes">SCARB2.</italic></p>
            </list-item>
            <list-item>
              <p><bold>Persons not of French-Canadian ancestry.</bold> It is appropriate to begin with sequence analysis of <italic toggle="yes">SCARB2.</italic> If only one pathogenic variant is identified, it is reasonable to perform gene-targeted deletion/duplication analysis next. However, to date, no <italic toggle="yes">SCARB2</italic> deletion/duplication has been reported to the authors&#x02019; knowledge.</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> for progressive myoclonic epilepsy (PME) or epilepsy that includes <italic toggle="yes">SCARB2</italic> and other genes of interest (see <xref ref-type="sec" rid="amrf.Differential_Diagnosis">Differential Diagnosis</xref>) may also be used. Note: The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, mitochondrial sequencing, and genome sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">SCARB2</italic>) fails to confirm a diagnosis in an individual with features of action myoclonus &#x02013; renal failure syndrome. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
          <table-wrap id="amrf.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Action Myoclonus &#x02013; Renal Failure Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SCARB2</italic>
                  </td>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Estimated from <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-table4.pdf" content-type="local-data">Table 4</inline-supplementary-material>: 97.5%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis of pathogenic variants</td>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Footnote 5</td>
                </tr>
                <tr>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_amrf.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="amrf.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="amrf" object-id="amrf.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="amrf.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="amrf.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="amrf.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="amrf.TF.1.4">
                <label>4. </label>
                <p>About 20 pathogenic variants have been reported to date (see <xref ref-type="table" rid="amrf.T.scarb2_pathogenic_variants_discus">Tables 3</xref> and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-table4.pdf" content-type="local-data">4</inline-supplementary-material>). About 2.5% of affected individuals are compound heterozygotes with an identified intragenic pathogenic variant in one allele and an unidentified variant in the other.</p>
              </fn>
              <fn id="amrf.TF.1.5">
                <label>5. </label>
                <p>Testing for the pathogenic variants <xref ref-type="table" rid="amrf.T.scarb2_pathogenic_variants_discus">c.862C&#x0003e;T</xref> (see also <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-table4.pdf" content-type="local-data">Table 4</inline-supplementary-material>) (exon 7) and <xref ref-type="table" rid="amrf.T.scarb2_pathogenic_variants_discus">c.1187+3insT</xref> (see also <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-table4.pdf" content-type="local-data">Table 4</inline-supplementary-material>) (intron 9) in persons of French-Canadian origin. In this population, the vast majority of probands are homozygous for c.862C&#x0003e;T, whereas a small proportion are compound heterozygotes for both pathogenic variants [<xref ref-type="bibr" rid="amrf.REF.dibbens.2011.812">Dibbens et al 2011</xref>].</p>
              </fn>
              <fn id="amrf.TF.1.6">
                <label>6. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions and duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="amrf.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="amrf.Clinical_Description">
          <title>Clinical Description</title>
          <p>Action myoclonus &#x02013; renal failure (AMRF) syndrome typically comprises a continuum of two major (and ultimately fatal) manifestations: progressive myoclonic epilepsy (PME) and renal failure (<xref ref-type="table" rid="amrf.T.clinical_manifestations_of_amrf">Table 2</xref>); however, in some instances, renal failure is not observed. Thus, progressive myoclonus epilepsy without renal failure caused by biallelic <italic toggle="yes">SCARB2</italic> pathogenic variants is considered to be one end of the spectrum of AMRF [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.dibbens.2009.532">Dibbens et al 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.guerrerol_pez.2012.1826">Guerrero-L&#x000f3;pez et al 2012</xref>, <xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>].</p>
          <p>The age of onset varies, even within the same family.</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic manifestations can appear before (in 1/3 of the cases), simultaneously, or after the renal manifestations. In juvenile AMRF onset is usually in the late teens or early twenties [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>In some persons renal manifestations occur early (late childhood or early teens) and neurologic involvement much later (late 20s or early 30s) [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.hopfner.2011.134">Hopfner et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>In three persons of Japanese heritage who did not develop renal failure, neurologic manifestations appeared in the fifth or sixth decade [<xref ref-type="bibr" rid="amrf.REF.higashiyama.2013.552">Higashiyama et al 2013</xref>, <xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al 2014</xref>].</p>
            </list-item>
          </list>
          <p>The neurologic and renal manifestations progress independently. Of note, the neurologic manifestations are not the result of a metabolic encephalopathy due to renal failure and are not improved by dialysis or by renal transplantation [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>].</p>
          <p>Even in the same family, the number and order of appearance of the clinical manifestations can vary. Neurologic manifestations may occur first or in isolation in some family members and renal manifestations may be first or isolated in other family members [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>]. In some families, all affected individuals have neurologic manifestations and none develop renal failure [<xref ref-type="bibr" rid="amrf.REF.dibbens.2009.532">Dibbens et al 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.guerrerol_pez.2012.1826">Guerrero-L&#x000f3;pez et al 2012</xref>, <xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al 2014</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2014">Perandones et al 2014</xref>, <xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>]; however, some affected family members have proteinuria [<xref ref-type="bibr" rid="amrf.REF.dibbens.2009.532">Dibbens et al 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.guerrerol_pez.2012.1826">Guerrero-L&#x000f3;pez et al 2012</xref>] or reduced creatinine clearance [<xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>].</p>
          <p>The disease progresses relentlessly with neurologic deterioration (especially increasing severity of myoclonus) and renal failure leading to death within seven to 15 years after onset.</p>
          <table-wrap id="amrf.T.clinical_manifestations_of_amrf" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Clinical Manifestations of AMRF</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Onset</th>
                  <th id="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Major Manifestations</th>
                  <th id="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">CNS Involvement</th>
                  <th id="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Renal Disease</th>
                  <th id="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Other Possible Manifestations</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Juvenile</bold>
                  </td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PME and RF</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Tremor</p></list-item><list-item><p>Progressive action myoclonus</p></list-item><list-item><p>Myoclonus at rest</p></list-item><list-item><p>Ataxia, dysarthria</p></list-item><list-item><p>Severe epileptic photosensitivity</p></list-item><list-item><p>GTCS (rare at onset; relatively infrequent even in later stages)</p></list-item></list>
</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Proteinuria (progressing from mild to severe)</p></list-item><list-item><p>Segmental GP and/or TP</p></list-item><list-item><p>Renal failure</p></list-item></list>
</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>PNP</p></list-item><list-item><p>SNHL</p></list-item><list-item><p>DCM</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">PME</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Tremor</p></list-item><list-item><p>Progressive action myoclonus</p></list-item><list-item><p>Myoclonus at rest</p></list-item><list-item><p>Ataxia, dysarthria</p></list-item><list-item><p>Severe epileptic photosensitivity</p></list-item><list-item><p>GTCS (infrequent at onset)</p></list-item></list>
</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Mild proteinuria</p></list-item><list-item><p>Mild decrease of creatinine clearance</p></list-item></list>
</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>PNP</p></list-item><list-item><p>Mild generalized muscle atrophy w/out fasciculations</p></list-item></list>
</td>
                </tr>
                <tr>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">RF</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Neurologic manifestations as listed above may develop late in the course of the disease</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>May begin in early childhood or early teens</p></list-item><list-item><p>Proteinuria, progressive</p></list-item><list-item><p>Segmental GP</p></list-item><list-item><p>TP</p></list-item><list-item><p>Renal failure</p></list-item></list>
</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_5" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Late</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">PME</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Tremor</p></list-item><list-item><p>Ataxia, dysarthria</p></list-item><list-item><p>Progressive action myoclonus</p></list-item><list-item><p>GTCS may occur infrequently</p></list-item><list-item><p>Cognitive decline</p></list-item></list>
</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">None reported</td>
                  <td headers="hd_h_amrf.T.clinical_manifestations_of_amrf_1_1_1_5" valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>PME = progressive myoclonus epilepsy</p>
              </fn>
              <fn>
                <p>RF = renal failure</p>
              </fn>
              <fn>
                <p>GTCS = generalized tonic-clonic seizures</p>
              </fn>
              <fn>
                <p>GP = glomerulopathy</p>
              </fn>
              <fn>
                <p>TP = tubulopathy</p>
              </fn>
              <fn>
                <p>PNP = peripheral neuropathy</p>
              </fn>
              <fn>
                <p>SNHL = sensorineural hearing loss</p>
              </fn>
              <fn>
                <p>DCM = dilated cardiomyopathy</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <sec id="amrf.Neurologic_Disease">
            <title>Neurologic Disease</title>
            <p><bold>Fine tremor.</bold> The disease begins with bilateral fine tremor of the fingers that is noted at rest and increased by delicate movement such as writing, by intention of movement, and by maintaining an attitude in horizontal extension [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.vadlamudi.2006.1310">Vadlamudi et al 2006</xref>]. The tremor can be relieved by alcohol [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.andermann.2011">Andermann 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.guerrerol_pez.2012.1826">Guerrero-L&#x000f3;pez et al 2012</xref>]. It becomes progressively worse until it is masked by myoclonic jerks [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.vadlamudi.2006.1310">Vadlamudi et al 2006</xref>].</p>
            <p><bold>Action myoclonus.</bold> The fine tremor is followed by jerking movements first of the upper and then the lower extremities. Referred to as action myoclonus, these jerking movements are typically triggered by movements or intended movements. They are asynchronous and of variable severity.</p>
            <p>With time, myoclonic jerks involve the proximal limbs; their amplitude and number increases by movements of the limbs, typically by walking down stairs. Action myoclonus can also involve the trunk. Attempts at speaking and executed speech can induce myoclonus of the bulbar musculature, contributing to the dysarthria. There is no palatal myoclonus.</p>
            <p>Action myoclonus, which is also reflex-sensitive to touch over the distal extremities, can be exacerbated by anxiety, excitement, stress, and fatigue [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>] and by auditory stimuli [<xref ref-type="bibr" rid="amrf.REF.perandones.2012.1200">Perandones et al 2012</xref>]. Some patients exhibit occasional myoclonus in response to startle [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>]. Of note, myoclonic jerks were significantly less frequent during pregnancy in one patient [<xref ref-type="bibr" rid="amrf.REF.amrom">Amrom et al, In press</xref>].</p>
            <p>Action myoclonus represents the most disabling manifestation: it prevents affected individuals from being able to feed themselves and, thus, they become malnourished unless they receive assistance with feeding or are fed by artificial means. In the final stages, they may become bedridden or wheelchair bound. Swallowing difficulties can lead to aspiration pneumonia and death [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.vadlamudi.2006.1310">Vadlamudi et al 2006</xref>].</p>
            <p><bold>Myoclonus at rest.</bold> Subtle myoclonic movements of the eyelids, jaws, and perioral musculature appear at rest and while speaking. Ocular dysmetria can occur later in the disease course.</p>
            <p><bold>Clonic-tonic-clonic seizures,</bold> which can be diurnal or nocturnal, begin with generalized clonic jerking with preserved consciousness and proceed to unconsciousness with tonic-clonic features. They occur infrequently, starting with one per annum initially [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>]. TV viewing or other light stimulation may trigger generalized myoclonic seizures or tonic-clonic seizures [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>]. Photosensitivity can become so severe that affected individuals choose to live in almost complete darkness [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>].</p>
            <p><bold>Ataxia and dysarthria,</bold> common findings, can be distinguished from myoclonic jerks by the presence of the cerebellar abnormalities of pendular reflexes, abnormal rebound, and hypermetric ocular saccades.</p>
            <p><bold>Progressive myoclonus ataxia.</bold> Some patients develop significant progressive ataxia before or after the appearance of myoclonus and, thus, have been reported to have &#x02018;progressive myoclonus ataxia.&#x02019;</p>
            <p>A woman age 29 years had a history of clumsiness in the lower limbs, mild gait instability, and difficulties in riding a bicycle beginning at age 21 years, two years before the onset of progressive myoclonus at age 23 years. Renal failure was evident at age 25 years, and bilateral severe SNHL was diagnosed at age 27 years [<xref ref-type="bibr" rid="amrf.REF.perandones.2012.1200">Perandones et al 2012</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2014">Perandones et al 2014</xref>].</p>
            <p>A woman age 22 years developed postural hand tremor exacerbated by fine voluntary movements and stress. The tremor slowly worsened with multifocal spontaneous and stimulus-sensitive myoclonic jerks. No other seizures were reported, and the EEG did not show any epileptic activity (of note, the patient was taking several antiepileptic medications). Ataxia was first reported when she was wheel-chair bound at age 27 years. The co-occurrence of tremor, myoclonus, and ataxia in the same patient &#x02013; without generalized tonic-clonic seizures &#x02013; increases the complexity of the clinical picture of this disorder [<xref ref-type="bibr" rid="amrf.REF.guerrerol_pez.2012.1826">Guerrero-L&#x000f3;pez et al 2012</xref>].</p>
            <p><bold>Peripheral neuropathy.</bold> In some families, a sensorimotor peripheral neuropathy (most often predominantly demyelinating or more rarely axonal) may be present.</p>
            <p>Some affected individuals may be diagnosed with a predominantly demyelinating peripheral neuropathy before the onset of renal failure [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.costello.2009.898">Costello et al 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.dibbens.2011.812">Dibbens et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.hopfner.2011.134">Hopfner et al 2011</xref>]. In the German Family I reported by <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al [2004]</xref>, one family member with AMRF who was asymptomatic for polyneuropathy was initially found to have a predominantly axonal neuropathy by nerve conduction studies; several years later, he and his two affected sibs were reported to have predominantly demyelinating polyneuropathy [<xref ref-type="bibr" rid="amrf.REF.hopfner.2011.134">Hopfner et al 2011</xref>].</p>
            <p><bold>Mild generalized muscle atrophy</bold> was observed in one individual who exhibited mild generalized reduced tone and no fasciculations [<xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>].</p>
          </sec>
          <sec id="amrf.Renal_Disease">
            <title>Renal Disease</title>
            <p>Mild proteinuria may progress to nephrotic syndrome and ultimately to renal failure (<xref ref-type="table" rid="amrf.T.clinical_manifestations_of_amrf">Table 2</xref>).</p>
            <p>Dialysis and renal transplantation can prolong survival, but do not improve the neurologic features.</p>
          </sec>
          <sec id="amrf.Mental_Status">
            <title>Mental Status</title>
            <p><bold>Cognitive function.</bold> Unlike individuals with most other types of progressive myoclonus epilepsy, the majority of individuals with AMRF syndrome remain mentally alert. However, dementia has been documented in two unrelated individuals of Japanese ancestry, one with the juvenile-onset form, and the other with the late-onset form, who have different <italic toggle="yes">SCARB2</italic> pathogenic variants [<xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al 2014</xref>].</p>
            <p><bold>Psychological complications.</bold> Individuals with AMRF may exhibit somatic concerns or depressed mood, or may in exceptional cases commit suicide [<xref ref-type="bibr" rid="amrf.REF.amrom">Amrom et al, In press</xref>].</p>
          </sec>
          <sec id="amrf.Other_Findings">
            <title>Other Findings</title>
            <p><bold>Cardiac disease.</bold> In a German family, echocardiography revealed dilated cardiomyopathy in two of three affected sibs at ages 14 and 21 years [<xref ref-type="bibr" rid="amrf.REF.hopfner.2011.134">Hopfner et al 2011</xref>]. In addition, these sibs had sensorimotor peripheral neuropathy.</p>
            <p><bold>Hearing loss / deafness.</bold> Frank or subclinical sensorineural hearing loss (SNHL) can be part of the spectrum of AMRF syndrome. Three individuals with AMRF had adult-onset SNHL which was mild in one individual from one family [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>], and severe and asymmetric in an individual from a second family [<xref ref-type="bibr" rid="amrf.REF.perandones.2012.1200">Perandones et al 2012</xref>], in which a sister had preclinical hearing loss [<xref ref-type="bibr" rid="amrf.REF.perandones.2014">Perandones et al 2014</xref>].</p>
            <p>Thus in the same family, the SNHL can be severe or subclinical or absent [<xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2012.1200">Perandones et al 2012</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2014">Perandones et al 2014</xref>].</p>
            <p><bold>Common causes of death in AMRF.</bold> Sudden death may occur during or after a generalized epileptic seizure due to aspiration, severe myoclonus and unmanageable saliva, or an undetermined cause. Death can also occur due to aspiration pneumonia, renal failure, or rejection of a renal transplant [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.vadlamudi.2006.1310">Vadlamudi et al 2006</xref>, <xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>].</p>
          </sec>
          <sec id="amrf.LateOnset_AMRF">
            <title>Late-Onset AMRF</title>
            <p>Disease onset in the fifth or sixth decade has been reported in two Japanese families.</p>
            <p><xref ref-type="bibr" rid="amrf.REF.higashiyama.2013.552">Higashiyama et al [2013]</xref> reported one family with two sibs with AMRF without renal failure. The sister presented with myoclonic jerks at age 43 years; her older brother presented with gait difficulties at age 52 years. Both were homozygous for the <italic toggle="yes">SCARB2</italic> pathogenic variant c.1385_1390del6insATGCATGCACC.</p>
            <p><xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al [2014]</xref> reported single affected individuals from two other Japanese families, one of whom (Patient 1) had late-onset disease. Patient 1 presented with onset of difficulties going up and down the stairs at age 45 years. Of note, he was homozygous for the same pathogenic variant as the two sibs reported by <xref ref-type="bibr" rid="amrf.REF.higashiyama.2013.552">Higashiyama et al [2013]</xref>. Although the two families with the late-onset form are likely related as they originate from the same rural area, the precise relationship is unknown [Hiroshi Doi, 2014, personal communication; Hitoshi Takahashi, June 2014, personal communication]. Of note, Patient 2 reported by <xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al [2014]</xref> presented at age 20 years, was unrelated to Patient 1, and was homozygous for a different <italic toggle="yes">SCARB2</italic> pathogenic variant.</p>
          </sec>
          <sec id="amrf.Specialized_Studies">
            <title>Specialized Studies</title>
            <p><bold>EEG findings</bold> [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>]. Background activity may be normal in some patients or show diffuse slowing at 6.5 to 7.5 Hz. Relatively low-voltage spike and spike-wave discharges, rather infrequent, bilaterally synchronous and generalized or confined to the central vertex or both occipital regions, increased by hyperventilation and intermittent photic stimulation, may be present.</p>
            <p>Some of the brief spike potentials are difficult to distinguish from muscle potentials except that they are seen at the vertex where there is no muscle artefact. The electromyogram myoclonic potentials are sometimes associated with cerebral potentials and at other times occur independently, suggesting a subcortical origin with a secondary corticoreticular generalization.</p>
            <p>Intermittent photic stimulation may produce whole-body myoclonus with multiple spikes in the EEG record associated with slow waves [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>]. These generalized spike-polyspike-wave bursts can outlast the duration of light stimulation [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>].</p>
            <p>Myoclonic seizures can be triggered by eye closure and resolve by eye opening [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>].</p>
            <p>Overnight sleep recording can show fast spikes over the vertex spreading to bilateral frontocentral regions during rapid eye movement (REM) sleep.</p>
            <p>Follow up over the course of the disease shows a preserved alpha background activity at disease onset, with rare generalized or focal epileptiform discharges. Over the years, irregular slower theta and delta waves progressively intermix with the alpha waves, and the epileptic activity becomes more frequent [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>].</p>
            <p><bold>MRI findings.</bold> Brain MRI may be normal or show mild diffuse cerebral and cerebellar atrophy [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2012.1200">Perandones et al 2012</xref>].</p>
            <p><bold>Electromyography findings.</bold> Nerve conduction analysis can show slowed nerve conduction velocities and prolonged F-waves, consistent with a mixed, mainly demyelinating polyneuropathy [<xref ref-type="bibr" rid="amrf.REF.dibbens.2011.812">Dibbens et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.hopfner.2011.134">Hopfner et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>].</p>
            <p>In one patient, concentric needle electromyography (EMG) was suggestive of chronic anterior horn involvement [<xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>].</p>
            <p><bold>Brain histologic findings.</bold> A constant and pathognomonic finding is the presence of small and large autofluorescent pigment granules up to 10 &#x000b5;m in size in astrocytes and in certain cells in the meninges. The pigment granules are more prominent in laminae I and II of the cerebral cortex, the globus pallidus and putamen, and the Bergmann astrocytes in the cerebellar cortex; they are not seen in the thalamus, brain stem nuclei, dentate nuclei of the cerebellum, or spinal cord gray matter. The granules are both separate from as well as adjacent to glial cell nuclei, suggesting that at least some were within astrocytes [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>, <xref ref-type="bibr" rid="amrf.REF.berkovic.2008.673">Berkovic et al 2008</xref>].</p>
            <p>Neurons contain normal amounts of lipofuscin and no pigment granules [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>]. In two affected individuals of Japanese ancestry extraneuronal brown pigment deposition, exclusively in astrocytic cytoplasm and surrounded by a membrane, was widely scattered throughout the brain [<xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al 2014</xref>].</p>
            <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-spec_studies.pdf" content-type="local-data">here</inline-supplementary-material> for information about specialized studies for biologic and histologic findings.</p>
          </sec>
        </sec>
        <sec id="amrf.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No clear genotype-phenotype correlation is evident.</p>
          <p>Disease severity may vary among affected individuals within a family who have the same pathogenic variants. In some affected individuals, phenotypic variability may be explained by the presence of an additional pathogenic variant in another epilepsy-related gene [<xref ref-type="bibr" rid="amrf.REF.he.2014.598">He et al 2014</xref>].</p>
        </sec>
        <sec id="amrf.Nomenclature">
          <title>Nomenclature</title>
          <p>Action myoclonus &#x02013; renal failure (AMRF) syndrome has been referred to as:</p>
          <list list-type="bullet">
            <list-item>
              <p>Familial myoclonus with renal failure</p>
            </list-item>
            <list-item>
              <p>Progressive myoclonus epilepsy with renal failure</p>
            </list-item>
            <list-item>
              <p>Epilepsy, progressive myoclonic 4, with or without renal failure, EPM4. However, the presence or absence of renal failure represents only part of the clinical spectrum of AMRF.</p>
            </list-item>
          </list>
          <p>The term progressive myoclonus epilepsy (PME) covers a large group of diseases characterized by myoclonus, epilepsy, and progressive neurologic deterioration.</p>
        </sec>
        <sec id="amrf.Prevalence">
          <title>Prevalence</title>
          <p>Exact prevalence figures are not available. To the authors&#x02019; knowledge, 38 affected individuals from 26 families have been reported to date.</p>
          <p>AMRF was first reported in several French-Canadian families [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>]; it occurs worldwide, including Europe; North, Central and South America; Australia; Asia; and the Middle-East.</p>
          <p>Families without renal failure have been reported in Italy [<xref ref-type="bibr" rid="amrf.REF.dibbens.2009.532">Dibbens et al 2009</xref>], Spain [<xref ref-type="bibr" rid="amrf.REF.guerrerol_pez.2012.1826">Guerrero-L&#x000f3;pez et al 2012</xref>], Asia [<xref ref-type="bibr" rid="amrf.REF.higashiyama.2013.552">Higashiyama et al 2013</xref>, <xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al 2014</xref>, <xref ref-type="bibr" rid="amrf.REF.he.2014.598">He et al 2014</xref>], and the Middle-East [<xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>].</p>
        </sec>
      </sec>
      <sec id="amrf.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are associated with biallelic mutation of <italic toggle="yes">SCARB2</italic>.</p>
        <p>Of note, heterozygous variants in <italic toggle="yes">SCARB2</italic> may modify the phenotype of <related-object link-type="booklink" source-id="gene" document-id="gaucher" document-type="chapter">Gaucher disease</related-object> [<xref ref-type="bibr" rid="amrf.REF.velayati.2011.1232">Velayati et al 2011</xref>].</p>
        <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-SCARB2_Parkinson_Dis.pdf" content-type="local-data">here</inline-supplementary-material> for information on possible population-based association of <italic toggle="yes">SCARB2</italic> and Parkinson disease.</p>
      </sec>
      <sec id="amrf.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>At the onset of the disease, three non-progressive conditions should be considered in the differential diagnosis:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Cortical tremor syndrome.</bold> At the onset of fine tremor, cortical tremor syndrome (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS601068">Epilepsy, familial adult myoclonic: OMIM Phenotypic Series</ext-link>) should be considered [<xref ref-type="bibr" rid="amrf.REF.ikeda.1990.1561">Ikeda et al 1990</xref>, <xref ref-type="bibr" rid="amrf.REF.brown.2004.2151">Brown 2004</xref>]. Cortical tremor syndrome, also referred to as familial adult myoclonic epilepsy (FAME) and familial cortical myoclonic tremor associated with epilepsy (FCMTE), is characterized by adult-onset cortical myoclonus of the extremities and seizures (mainly generalized tonic-clonic, less frequently myoclonic seizures or complex partial seizures) in 40% of affected individuals. It usually has a favorable outcome.</p>
            <p>Cortical tremor syndrome is inherited in an autosomal dominant manner in the majority of families. Five loci have been identified, three with autosomal dominant inheritance [<xref ref-type="bibr" rid="amrf.REF.guerrini.2001.2459">Guerrini et al 2001</xref>, <xref ref-type="bibr" rid="amrf.REF.depienne.2010.2000">Depienne et al 2010</xref>, <xref ref-type="bibr" rid="amrf.REF.striano.2010.669">Striano et al 2010</xref>, <xref ref-type="bibr" rid="amrf.REF.coppola.2011.1245">Coppola et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.crompton.2012.474">Crompton et al 2012</xref>]. In one family with autosomal dominant inheritance, a heterozygous pathogenic variant in <italic toggle="yes">ACMSD</italic> has been identified [<xref ref-type="bibr" rid="amrf.REF.mart_mass_.2013.1399">Mart&#x000ed;-Mass&#x000f3; et al 2013</xref>]. In one family with autosomal recessive inheritance, homozygous <italic toggle="yes">CNTN2</italic> pathogenic variants have been identified [<xref ref-type="bibr" rid="amrf.REF.stogmann.2013.1155">Stogmann et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Juvenile myoclonic epilepsy (JME).</bold> JME, which has a favorable outcome, should be considered at the onset of myoclonus. Individuals with JME have a normal neurologic examination and the EEG background activity is undisturbed. The myoclonus is not progressive [<xref ref-type="bibr" rid="amrf.REF.zifkin.2005.147">Zifkin et al 2005</xref>, <xref ref-type="bibr" rid="amrf.REF.genton.2013.s8">Genton et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="myo-dystonia" document-type="chapter"><bold>Myoclonus-dystonia</bold></related-object>
<bold>(DYT11).</bold> The association of myoclonus and dystonia suggests DYT11 [<xref ref-type="bibr" rid="amrf.REF.klein.2002">Klein 2002</xref>]. Onset of myoclonus is usually in the first or second decade of life; the myoclonus is subcortical in origin [<xref ref-type="bibr" rid="amrf.REF.roze.2008.1010">Roze et al 2008</xref>]; about half of affected individuals have segmental dystonia. No other neurologic features (in particular ataxia and cognitive deficits) are associated. DYT11 is inherited in an autosomal dominant manner. Familial myoclonus-dystonia is associated with pathogenic variants in <italic toggle="yes">SGCE</italic> [<xref ref-type="bibr" rid="amrf.REF.zimprich.2001.66">Zimprich et al 2001</xref>].</p>
          </list-item>
        </list>
        <p>In individuals with a PME phenotype who do not have biallelic <italic toggle="yes">SCARB2</italic> pathogenic variants, the following disorders should be considered:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="epm1" document-type="chapter"><bold>Unverricht-Lundborg disease</bold></related-object>
<bold>(EPM1),</bold> also referred to as <bold>EPM1A,</bold> is a progressive myoclonus epilepsy syndrome with an earlier age of onset and a slower rate of disease progression than AMRF; cognition is normal or mildly reduced [<xref ref-type="bibr" rid="amrf.REF.k_lvi_inen.2008.549">K&#x000e4;lvi&#x000e4;inen et al 2008</xref>, <xref ref-type="bibr" rid="amrf.REF.genton.2010.37">Genton 2010</xref>]. Inheritance is autosomal recessive; biallelic pathogenic variants in <italic toggle="yes">CSTB</italic> (encoding cystatin B) are causative<italic toggle="yes">.</italic></p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="me-ataxia" document-type="chapter"><bold><italic toggle="yes">PRICKLE1</italic>-related progressive myoclonus epilepsy with ataxia</bold></related-object>
<bold>(EPM1B)</bold> is a progressive myoclonus epilepsy-ataxia syndrome which presents in childhood. Ataxia begins at ages 4 to 5 years and evolves to PME with ataxia and mild or no cognitive decline. Impaired upward gaze has been observed in several affected individuals [<xref ref-type="bibr" rid="amrf.REF.berkovic.2005.652">Berkovic et al 2005</xref>, <xref ref-type="bibr" rid="amrf.REF.bassuk.2008.572">Bassuk et al 2008</xref>]. PRICKLE1-related PME with ataxia is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="lafora" document-type="chapter"><bold>Progressive myoclonus epilepsy, Lafora type</bold></related-object> is considered in individuals with visual hallucinations (occipital epilepsy) and cognitive decline. Skin biopsy shows pathognomonic Lafora bodies [<xref ref-type="bibr" rid="amrf.REF.carpenter.1974.531">Carpenter et al 1974</xref>, <xref ref-type="bibr" rid="amrf.REF.carpenter.1981.1564">Carpenter &#x00026; Karpati 1981</xref>]. Inheritance is autosomal recessive. Biallelic pathogenic variants in either <italic toggle="yes">EPM2A</italic> or <italic toggle="yes">NHLRC1</italic> (<italic toggle="yes">EPM2B</italic>) are causative [<xref ref-type="bibr" rid="amrf.REF.minassian.1998.171">Minassian et al 1998</xref>, <xref ref-type="bibr" rid="amrf.REF.chan.2003.125">Chan et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>EPM5</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613832">613832</ext-link>) is characterized by myoclonic seizures, cerebellar signs and deterioration of cognition as well as visual impairment [<xref ref-type="bibr" rid="amrf.REF.bird.1978.140">Bird and Shaw 1978</xref>]. Some phenotypic findings may be similar to <related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter">dentatorubro-pallido-luysian atrophy</related-object> (DRPLA) [<xref ref-type="bibr" rid="amrf.REF.bird.1978.140">Bird &#x00026; Shaw 1978</xref>, <xref ref-type="bibr" rid="amrf.REF.tsuji.2012.587">Tsuji 2012</xref>]. Inheritance is autosomal dominant; heterozygous pathogenic variants in <italic toggle="yes">PRICKLE2</italic> are causative [<xref ref-type="bibr" rid="amrf.REF.tao.2011.138">Tao et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Progressive <italic toggle="yes">m</italic>yoclonic <italic toggle="yes">e</italic>pilepsy and <italic toggle="yes">a</italic>taxia due to <italic toggle="yes">KCNC1</italic> channel mutation B (MEAK)</bold> is clinically similar to Unverricht-Lundborg disease. Inheritance is autosomal dominant; a recurrent <italic toggle="yes">de novo</italic>
<italic toggle="yes">KCNC1</italic> pathogenic variant, c.959G&#x0003e;A (p.Arg320His) which causes loss of function of KV3.1, a subunit of the KV3 voltage-gated potassium ion channels, is causative [<xref ref-type="bibr" rid="amrf.REF.muona.2015.39">Muona et al 2015</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter"><bold>Neuronal ceroid-lipofuscinoses</bold></related-object>
<bold>(NCL).</bold> In adult NCL (ANCL) (formerly called Kufs disease), initial signs and symptoms usually appear around age 30 years (range: teens to &#x0003e;50 years), with death occurring about ten years later. ANCL is clinically and genetically heterogeneous, and is inherited in either an autosomal dominant or autosomal recessive manner. It is distinguished from most other forms of NCL by preserved vision. The two major ANCL phenotypes are type A (the major form) and type B [<xref ref-type="bibr" rid="amrf.REF.berkovic.1988.27">Berkovic et al 1988</xref>].</p>
            <p>Note: ANCL type B is not part of the differential diagnosis of AMRF since it is characterized by behavioral abnormalities and dementia which may be associated with motor dysfunction, ataxia, extrapyramidal signs, and suprabulbar (brain stem) signs [<xref ref-type="bibr" rid="amrf.REF.berkovic.1988.27">Berkovic et al 1988</xref>, <xref ref-type="bibr" rid="amrf.REF.smith.2013.1417">Smith et al 2013</xref>].</p>
            <p>ANCL type A is characterized by progressive myoclonic epilepsy with cognitive deterioration, ataxia, and late-occurring pyramidal and extrapyramidal signs. It can be inherited in either an autosomal dominant or autosomal recessive manner. The autosomal dominant forms have intraneuronal granular osmiophilic deposits (GRODs) observed on electron microscopy [<xref ref-type="bibr" rid="amrf.REF.burneo.2003.841">Burneo et al 2003</xref>, <xref ref-type="bibr" rid="amrf.REF.nijssen.2003.574">Nijssen et al 2003</xref>]. Some autosomal dominant forms are caused by heterozygous pathogenic variants in <italic toggle="yes">DNAJC5</italic> [<xref ref-type="bibr" rid="amrf.REF.noskov_.2011.241">Noskov&#x000e1; et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.cadieuxdion.2013.571">Cadieux-Dion et al 2013</xref>, <xref ref-type="bibr" rid="amrf.REF.cadieuxdion.2014.470">Cadieux-Dion et al 2014</xref>]. The autosomal recessive form is mainly caused by biallelic pathogenic variants in <italic toggle="yes">CLN6</italic> [<xref ref-type="bibr" rid="amrf.REF.arsov.2011.566">Arsov et al 2011</xref>].</p>
            <p>Other forms of ANCL type A, associated with visual loss, can result from biallelic pathogenic variants in <italic toggle="yes">CLN1</italic> [<xref ref-type="bibr" rid="amrf.REF.van_diggelen.2001.269">van Diggelen et al 2001</xref>, <xref ref-type="bibr" rid="amrf.REF.ramadan.2007.387">Ramadan et al 2007</xref>], <italic toggle="yes">CLN5</italic> [<xref ref-type="bibr" rid="amrf.REF.sleat.2009.1708">Sleat et al 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.xin.2010.565">Xin et al 2010</xref>] or <italic toggle="yes">GRN</italic> [<xref ref-type="bibr" rid="amrf.REF.smith.2012.1102">Smith et al 2012</xref>]. Inheritance is autosomal recessive.</p>
            <p>A juvenile form of NCL with autosomal recessive inheritance and GROD is associated with pathogenic variants in the gene encoding palmitoyl-protein thioesterase (PPT), which are also seen in the infantile form of NCL (CLN1) [<xref ref-type="bibr" rid="amrf.REF.mitchison.1998.291">Mitchison et al 1998</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Sialidosis type 1</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/256550">256550</ext-link>) is characterized by PME with cognitive decline and can be assessed with neuroophthalmologic examination, including electroretinography [<xref ref-type="bibr" rid="amrf.REF.boustany.2013.583">Boustany 2013</xref>, <xref ref-type="bibr" rid="amrf.REF.mink.2013.1101">Mink et al 2013</xref>]. Sialidosis type 1 is inherited in an autosomal recessive manner and caused by biallelic pathogenic variants of <italic toggle="yes">NEU1</italic> [<xref ref-type="bibr" rid="amrf.REF.bonten.2000.2715">Bonten et al 2000</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="merrf" document-type="chapter"><bold>MERRF</bold></related-object>
<bold>(myoclonic epilepsy with ragged red fibers)</bold> is a multisystem disorder characterized by myoclonus, which is often the first symptom, followed by generalized epilepsy, ataxia, weakness, and dementia. In individuals with MERRF, blood and cerebrospinal fluid concentrations of lactate and pyruvate are commonly elevated at rest and increase excessively after moderate activity [<xref ref-type="bibr" rid="amrf.REF.bindoff.2012.92">Bindoff &#x00026; Engelsen 2012</xref>, <xref ref-type="bibr" rid="amrf.REF.finsterer.2012.316">Finsterer &#x00026; Zarrouk Mahjoub 2012</xref>]. MERRF is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="gaucher" document-type="chapter"><bold>Gaucher disease type 3</bold></related-object><bold>,</bold> characterized by the presence of primary neurologic disease, may have onset before age two years, but often has a more slowly progressive course, with survival into the third or fourth decade. Saccade initiation failure is a common and early manifestation &#x02013; suggestive of early dysfunction of supranuclear ocular motor control &#x02013; and can be detected during induced optokinetic or vestibular nystagmus [<xref ref-type="bibr" rid="amrf.REF.harris.1999.289">Harris et al 1999</xref>]. Gaucher disease is inherited in an autosomal recessive manner and is caused by biallelic pathogenic variants in <italic toggle="yes">GBA</italic> (encoding the enzyme &#x003b2;-glucocerebrosidase) [<xref ref-type="bibr" rid="amrf.REF.tsuji.1987.570">Tsuji et al 1987</xref>, <xref ref-type="bibr" rid="amrf.REF.dahl.1988.296">Dahl et al 1988</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Familial encephalopathy with neuroserpin inclusion bodies (FENIB)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/604218">604218</ext-link>). Age of onset and clinical manifestations vary considerably. The spectrum of clinical phenotypes ranges from cognitive decline/dementia, dysarthria, and tremors to various forms of refractory epilepsy including progressive myoclonus epilepsy (PME) and focal or generalized seizures. Inheritance is autosomal dominant; heterozygous pathogenic variants in <italic toggle="yes">SERPINI1</italic> are causative [<xref ref-type="bibr" rid="amrf.REF.hagen.2011.575">Hagen et al 2011</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter"><bold>DRPLA</bold></related-object>
<bold>(dentatorubral-pallidoluysian atrophy).</bold> Individuals with juvenile onset (age &#x0003c;20 years) of DRPLA present with PME and associated progressive cognitive deterioration and behavioral changes; whereas those with adult onset (age &#x0003e;20 years) of DRPLA present with ataxia, choreoathetosis, and dementia. DRPLA is relatively more common among the Japanese than in other ethnic populations [<xref ref-type="bibr" rid="amrf.REF.takano.1998.1060">Takano et al 1998</xref>]. DRPLA is inherited in an autosomal dominant manner and expansion of a CAG trinucleotide/polyglutamine tract in <italic toggle="yes">ATN1</italic> is causative [<xref ref-type="bibr" rid="amrf.REF.tsuji.2012.587">Tsuji 2012</xref>].</p>
          </list-item>
        </list>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS254800">Epilepsy, progressive myoclonic: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        <p><bold>Charcot-Marie-Tooth neuropathy with focal segmental glomerulonephritis</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614455">614455</ext-link>) should be considered in persons with peripheral neuropathy and glomerulonephritis [<xref ref-type="bibr" rid="amrf.REF.boyer.2011.2377">Boyer et al 2011</xref>]. Inheritance is autosomal dominant; heterozygous pathogenic variants in <italic toggle="yes">INF2</italic> are causative.</p>
      </sec>
      <sec id="amrf.Management">
        <title>Management</title>
        <sec id="amrf.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with action myoclonus &#x02013; renal failure (AMRF) syndrome, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Clinical evaluation including cognitive function and school performance, emotional features, eye movements, coordination, handwriting, walking</p>
            </list-item>
            <list-item>
              <p>Examination of myoclonus including evaluation at rest, with action, and in response to stimuli</p>
            </list-item>
            <list-item>
              <p>EEG evaluation including photosensitivity before therapy is initiated, as it is most characteristic before the use of anticonvulsant medication</p>
            </list-item>
            <list-item>
              <p>Renal function</p>
            </list-item>
            <list-item>
              <p>Audiogram and brain stem auditory evoked potentials (BAEPs) to assess the possibility of clinical or subclinical sensorineural hearing loss [<xref ref-type="bibr" rid="amrf.REF.rubboli.2011.2356">Rubboli et al 2011</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2012.1200">Perandones et al 2012</xref>, <xref ref-type="bibr" rid="amrf.REF.perandones.2014">Perandones et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Nerve conduction velocities (NCV) and needle electromyography (EMG)</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="amrf.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Neurologic manifestations.</bold> Symptomatic pharmacologic and psychosocial support is the mainstay of care for the neurologic manifestations. Response to treatment is variable and may deteriorate over time, necessitating rehabilitative management.</p>
          <list list-type="bullet">
            <list-item>
              <p>Valproic acid, the first drug of choice, diminishes myoclonus and the frequency of generalized seizures.</p>
            </list-item>
            <list-item>
              <p>Clonazepam may be used as add-on therapy for the treatment of myoclonic seizures.</p>
            </list-item>
            <list-item>
              <p>Levetiracetam appearss to be effective for both myoclonus and generalized seizures, and is recommended in women of child bearing age.</p>
              <p>Note: Lamotrigine is not effective in controlling the myoclonus, and may aggravate myoclonus in some patients [<xref ref-type="bibr" rid="amrf.REF.guerrini.1998.508">Guerrini et al 1998</xref>].</p>
            </list-item>
          </list>
          <p><bold>Renal manifestations.</bold> Renal insufficiency requires dialysis but response to treatment is poor, and renal transplantation is often necessary.</p>
        </sec>
        <sec id="amrf.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Standard measures for prevention of aspiration pneumonia and sudden unexpected death in epilepsy (SUDEP) should be followed; offering psychosocial support may be helpful.</p>
        </sec>
        <sec id="amrf.Surveillance">
          <title>Surveillance</title>
          <p>Lifelong clinical follow up should include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic</p>
              <list list-type="bullet">
                <list-item>
                  <p>Monitoring of antiepileptic drug treatment (drug levels and clinical assessment of biological effects);</p>
                </list-item>
                <list-item>
                  <p>Periodic assessment of hearing by audiograms and BAEPs and of the peripheral nerves by NCV and needle EMG.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Renal function monitoring by measurement of: blood pressure; body weight; serum concentrations of creatinine, albumin, and cholesterol; 24-hour urinary protein; and creatinine clearance</p>
            </list-item>
          </list>
        </sec>
        <sec id="amrf.AgentsCircumstances_to_avoid">
          <title>Agents/Circumstances to avoid</title>
          <p>Diphenylhydantoin, carbamazepine, oxcarbazepine, and possibly lamotrigine increase myoclonus and should be avoided in any individual with progressive myoclonic epilepsy (PME), including AMRF.</p>
        </sec>
        <sec id="amrf.Evaluation_of_relatives_at_risk">
          <title>Evaluation of relatives at risk</title>
          <p>See <xref ref-type="sec" rid="amrf.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="amrf.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Some antiepileptic drugs can lead to an increased risk of malformations, growth retardation, or neurodevelopmental disabilities in exposed fetuses. However, when pregnant women experience prolonged seizures during pregnancy, the risk of adverse fetal outcomes is increased. Therefore, it is recommended that women with a known seizure disorder continue to take antiepileptic drugs during pregnancy. Standard measures for prevention of fetopathy should be followed. These include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Possible changes of medication prior to pregnancy;</p>
            </list-item>
            <list-item>
              <p>Spacing of the antiepileptic drugs into four doses a day or taking extended release medications, so that the drug levels do not have significant peaks or troughs;</p>
            </list-item>
            <list-item>
              <p>Monitoring the dosages and drug levels of antiepileptic drugs during pregnancy and after the delivery.</p>
            </list-item>
          </list>
          <p>In addition, folic acid should be prescribed at 1 mg/day for all women of childbearing age and increased to 5 mg/day when planning a pregnancy (ideally 3 months prior to conception) and during the pregnancy, in order to prevent possible neural tube defects and other congenital malformations that can be associated with fetal exposure to antiepileptic drugs.</p>
        </sec>
        <sec id="amrf.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>A trial of enzyme replacement therapy (ERP) with imiglucerase (60 U/kg every two weeks) in two sibs with AMRF for a period of one year did not improve the clinical status. Substrate reduction therapy (SRT) with miglustat (600 mg daily) administered to one of the two sibs resulted in a significant reduction of myoclonus [<xref ref-type="bibr" rid="amrf.REF.chaves.2011.738">Chaves et al 2011</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov">Clinical Trials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="amrf.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="amrf.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Action myoclonus - renal failure (AMRF) syndrome is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="amrf.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">SCARB2</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The offspring of an individual with action myoclonus-renal failure syndrome are obligate heterozygotes (carriers) for a <italic toggle="yes">SCARB2</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the reproductive partner of an affected individual is a carrier of an <italic toggle="yes">SCARB2</italic> pathogenic variant, the offspring have a 50% chance of being affected and a 50% chance of being a carrier.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at 50% risk of being a carrier.</p>
          <p>
            <bold>Carrier (Heterozygote) Detection</bold>
          </p>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">SCARB2</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="amrf.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="amrf.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SCARB2</italic> pathogenic variants have been identified in an affected family member, prenatal testing or preimplantation genetic diagnosis for a pregnancy at increased risk for AMRF may be an option that a couple may wish to consider.</p>
          <p><bold>Fetal ultrasound examination.</bold> Prenatal testing by level 2 ultrasound examination does <bold>NOT</bold> detect AMRF, as disease onset is usually in the late teens or early twenties.</p>
        </sec>
      </sec>
      <sec id="amrf.Resources">
        <title>Resources</title>
      </sec>
      <sec id="amrf.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">SCARB2</italic> contains 5.5 kb with 12 exons and codes for two transcript variants; the longer variant is <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005506.3">NM_005506.3</ext-link>. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="amrf" object-id="amrf.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> A few sequence alterations that are not believed to have a primary role in disease causation have been found in unaffected individuals [Dibbens et al, unpublished data]. The extent to which these variants may influence the phenotype or clinical disease expression remains to be established.</p>
        <p><bold>Pathogenic variants.</bold> Known pathogenic variants include nonsense, missense, deletion, frameshift, and splice site variants, leading to retention of SCARB2 protein (previously known as LIMP-2) in the endoplasmic reticulum, but differentially affecting the binding to &#x003b2;-glucocerebrosidase (&#x003b2;-GC) [<xref ref-type="bibr" rid="amrf.REF.blanz.2010.563">Blanz et al 2010</xref>]. To the authors&#x02019; knowledge, all pathogenic variants identified to date are loss-of-function variants.</p>
        <p>See <xref ref-type="table" rid="amrf.T.scarb2_pathogenic_variants_discus">Table 3</xref> and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="amrf-table4.pdf" content-type="local-data">Table 4</inline-supplementary-material> (pdf).</p>
        <table-wrap id="amrf.T.scarb2_pathogenic_variants_discus" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p><italic toggle="yes">SCARB2</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.862C&#x0003e;T</td>
                <td headers="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln288Ter</td>
                <td headers="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_3" rowspan="2" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_005506.3">NM_005506.3</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_005497.1">NP_005497.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">c.1187+3insT</td>
                <td headers="hd_h_amrf.T.scarb2_pathogenic_variants_discus_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn>
              <p>Variants included are found in persons of French-Canadian origin; see <xref ref-type="table" rid="amrf.T.summary_of_molecular_genetic_test">Table 1</xref>, footnote 5.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The protein encoded by <italic toggle="yes">SCARB2</italic> (scavenger receptor class B, member 2) is a glycosylated 478-residue type III transmembrane protein that belongs to the CD36 family of scavenger receptors and is found in all cell types.</p>
        <p>SCARB2 (previously known as LIMP-2) has two known physiologic functions related to lysosome biology:</p>
        <list list-type="bullet">
          <list-item>
            <p>First, it is a major lysosomal integral membrane protein playing an important role in the biogenesis and maintenance of endosomes/lysosomes and interaction with the vesicle fission/fusion machinery [<xref ref-type="bibr" rid="amrf.REF.eskelinen.2003.137">Eskelinen et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>Second, it is a specific trafficking receptor of &#x003b2;-glucocerebrosidase (&#x003b2;-GC), the enzyme deficient in <related-object link-type="booklink" source-id="gene" document-id="gaucher" document-type="chapter">Gaucher disease</related-object> [<xref ref-type="bibr" rid="amrf.REF.reczek.2007.770">Reczek et al 2007</xref>]. It binds &#x003b2;-GC for transfer from the endoplasmic reticulum to the lysosome in a mannose-6-phosphate independent manner. The released &#x003b2;-GC remains in the endosome/lysosome whereas SCARB-2 then integrates in the limiting membrane of lysosomes, and is therefore also known as lysosomal integral membrane protein type 2 or LIMP-2 [<xref ref-type="bibr" rid="amrf.REF.reczek.2007.770">Reczek et al 2007</xref>, <xref ref-type="bibr" rid="amrf.REF.braulke.2009">Braulke &#x00026; Bonifacino 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.blanz.2010.563">Blanz et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p>Third, LIMP-2 has recently been found to represent a substrate for cathepsin-F, the enzyme involved in <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">ANCL</related-object> (Kufs disease) type B, suggesting that there may be links between the pathogenesis of different forms of PME.</p>
          </list-item>
        </list>
        <p>In addition, an extralysosomal function has been discovered in mice, human hearts, and myocytes in vivo, in which LIMP-2 has been identified as an important component of the structural organization of the cardiac myocyte intercalated disc, in particular adherens junctions where it interacts with N-cadherin [<xref ref-type="bibr" rid="amrf.REF.schroen.2007.1227">Schroen et al 2007</xref>].</p>
        <p>SCARB2 protein also functions as a receptor for various viruses.</p>
        <list list-type="bullet">
          <list-item>
            <p>It performs viral binding, viral internalization and viral uncoating of enterovirus 71 (EV71), the virus causing hand foot and mouth disease in young children or occasionally severe brain stem encephalitis and acute flaccid paralysis [<xref ref-type="bibr" rid="amrf.REF.yamayoshi.2009.798">Yamayoshi et al 2009</xref>, <xref ref-type="bibr" rid="amrf.REF.yamayoshi.2012a.32">Yamayoshi et al 2012a</xref>, <xref ref-type="bibr" rid="amrf.REF.yamayoshi.2012b.5686">Yamayoshi et al 2012b</xref>, <xref ref-type="bibr" rid="amrf.REF.yamayoshi.2013.3335">Yamayoshi et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p>It is also a receptor of the coxsackievirus A7, A14, and A16 [<xref ref-type="bibr" rid="amrf.REF.yamayoshi.2012b.5686">Yamayoshi et al 2012b</xref>].</p>
          </list-item>
        </list>
        <p><bold>Abnormal gene product.</bold> Action myoclonus &#x02013; renal failure syndrome (AMRF) is caused by deficiency of the SCARB2 protein.</p>
        <p>In AMRF, the beta-glucocerebrosidase (&#x003b2;-GC) structure itself is not affected, but its receptor in the trans-Golgi network (TGN) is abnormal, therefore altering its trafficking along its biosynthetic pathway. Biochemical analysis reveals a severe deficiency of &#x003b2;-GC in skin fibroblasts despite normal enzyme activity on standard leukocyte screening assays (Family D in <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al [2004]</xref>; unpublished data) [<xref ref-type="bibr" rid="amrf.REF.balreira.2008.2238">Balreira et al 2008</xref>, <xref ref-type="bibr" rid="amrf.REF.zeigler.2014.210">Zeigler et al 2014</xref>].</p>
        <p>This selective tissue involvement could be due to variable expression of the SCARB2 protein or to a variable pathway for the transport of &#x003b2;-GC, specific to tissue. Another hypothesis could be that SCARB2 is also a transporter of other as-yet unidentified proteins that also accumulate and/or are secreted in excess [<xref ref-type="bibr" rid="amrf.REF.amrom">Amrom et al, in press</xref>].</p>
        <p>AMRF is remarkable for the preservation of normal intelligence in the majority of patients. This could be explained by the observation of extraneuronal but no intraneuronal storage of autofluorescent pigmented material [<xref ref-type="bibr" rid="amrf.REF.andermann.1986.87">Andermann et al 1986</xref>, <xref ref-type="bibr" rid="amrf.REF.badhwar.2004.2173">Badhwar et al 2004</xref>]. However, two Japanese patients with AMRF developed dementia; it is unclear whether this is linked to AMRF or whether these patients had a second disease [<xref ref-type="bibr" rid="amrf.REF.fu.2014.551">Fu et al 2014</xref>]. Autofluorescent pigmented granules were observed in the cytoplasm of the astrocytes in these patients. Neuropathologic studies are needed in order to identify the nature of the storage material and to better localize the cellular organelles at the site of storage.</p>
        <p><bold>Animal models.</bold> The <italic toggle="yes">limp-2</italic>/<italic toggle="yes">scarb2</italic><sup>-/-</sup> knockout mice showed a triad encompassing pelvic junction obstruction, deafness, and peripheral demyelinating neuropathy [<xref ref-type="bibr" rid="amrf.REF.gamp.2003.631">Gamp et al 2003</xref>].</p>
        <p>Fluorescence immunohistochemical studies in these mice showed that deafness was due to an early loss of potassium channel KCNQ1/KCNE1 surface expression in marginal cells of the stria vascularis in the cochlea [<xref ref-type="bibr" rid="amrf.REF.knipper.2006.73">Knipper et al 2006</xref>]. In vivo studies in mice lacking limp-2 have shown that &#x003b2;-GC is no longer sorted to lysosomes but is secreted into the extracellular environment [<xref ref-type="bibr" rid="amrf.REF.reczek.2007.770">Reczek et al 2007</xref>].</p>
        <p>In the <italic toggle="yes">limp-2</italic>
null mice, embryologic cardiac development is normal; however, these mice fail to mount a hypertrophic cardiac response to AngII-induced hypertension, and develop dilated cardiomyopathy. limp-2 protein was thus shown to not only be an important lysosomal protein but also to be an important part of the intercalated disc of the heart and crucial for the hypertrophic response to cardiac loading [<xref ref-type="bibr" rid="amrf.REF.schroen.2007.1227">Schroen et al 2007</xref>].</p>
      </sec>
      <sec id="amrf.References">
        <title>References</title>
        <sec id="amrf.Literature_cited">
          <title>Literature cited</title>
          <ref-list id="amrf.Literature_cited.reflist0">
            <ref id="amrf.REF.amrom">
              <mixed-citation publication-type="book">Amrom D, Andermann F, Dibbens L, Berkovic S, Schwake M, Saftig P, Andermann E. Action myoclonus with renal failure syndrome (AMRF). In: Andermann E, Avanzini G, Genton P, Minassian B, eds. <italic toggle="yes">Progressive Myoclonus Epilepsies</italic>. New Barnet, UK: John Libbey; in press.</mixed-citation>
            </ref>
            <ref id="amrf.REF.andermann.1986.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolfe</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patry</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boileau</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology.</article-title>
                <source>Adv Neurol.</source>
                <year>1986</year>
                <volume>43</volume>
                <fpage>87</fpage>
                <lpage>103</lpage>
                <pub-id pub-id-type="pmid">3946122</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.andermann.2011">
              <mixed-citation publication-type="book">Andermann E. Action myoclonus &#x02013; renal failure syndrome. In: Shorvon SD, Andermann F, Guerrini R, eds. <italic toggle="yes">The Causes of Epilepsy: Common and Uncommon Causes in Adults and Children</italic>. Cambridge, UK: Cambridge University Press; 2011:169-71.</mixed-citation>
            </ref>
            <ref id="amrf.REF.arsov.2011.566">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Arsov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromhead</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McDougall</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sofia</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguglia</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meletti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, caused by mutations in CLN6.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2011</year>
                <volume>88</volume>
                <fpage>566</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">21549341</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.badhwar.2004.2173">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Badhwar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narayanan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodtmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berzen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caviness</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trenkwalder</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkelmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivest</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez-Cossio</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder.</article-title>
                <source>Brain.</source>
                <year>2004</year>
                <volume>127</volume>
                <fpage>2173</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">15364701</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.balreira.2008.2238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Balreira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caiola</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaves</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beirao</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lima</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azevedo</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2008</year>
                <volume>17</volume>
                <fpage>2238</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">18424452</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.bassuk.2008.572">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bassuk</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buller</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimojo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyata</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzalez-Alegre</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griesbach</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nashelsky</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vladar</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferguson</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelrod</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurnett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daoud</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazarib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straussberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walid</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korczyn</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slusarski</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Shanti</surname>
                    <given-names>HI</given-names>
                  </name>
                </person-group>
                <article-title>A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2008</year>
                <volume>83</volume>
                <fpage>572</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">18976727</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.berkovic.1988.27">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolfe</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <article-title>Kuf&#x02019;s disease: a critical reappraisal.</article-title>
                <source>Brain.</source>
                <year>1988</year>
                <volume>111</volume>
                <fpage>27</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">3284607</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.berkovic.2008.673">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oshlack</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katerelos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lullmann-Rauch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stankovich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalnins</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dowling</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faldini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Hooge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vadlamudi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macdonell</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgson</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayly</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savige</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smyth</surname>
                    <given-names>GK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Power</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Array-based gene discovery with three unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2008</year>
                <volume>82</volume>
                <fpage>673</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">18308289</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.berkovic.2005.652">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazarib</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walid</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manelis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korczyn</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiong</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandolfo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulley</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <article-title>A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping.</article-title>
                <source>Brain.</source>
                <year>2005</year>
                <volume>128</volume>
                <fpage>652</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15634728</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.bindoff.2012.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bindoff</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelsen</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial diseases and epilepsy.</article-title>
                <source>Epilepsia.</source>
                <year>2012</year>
                <volume>53</volume>
                <supplement>Suppl 4</supplement>
                <fpage>92</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22946726</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.bird.1978.140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>CM</given-names>
                  </name>
                </person-group>
                <article-title>Progressive myoclonus and epilepsy with dentatorubral degeneration: a clinicopathological study of the Ramsay Hunt syndrome.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>1978</year>
                <volume>41</volume>
                <fpage>140</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">632821</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.blanz.2010.563">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blanz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groth</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zachos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wehling</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2010</year>
                <volume>19</volume>
                <fpage>563</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">19933215</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.bonten.2000.2715">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonten</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arts</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Covanis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donati</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zammarchi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>d'Azzo</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis.</article-title>
                <source>Hum. Molec. Genet.</source>
                <volume>9</volume>
                <fpage>2715</fpage>
                <lpage>25</lpage>
                <year>2000</year>
                <pub-id pub-id-type="pmid">11063730</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.boustany.2013.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boustany</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Lysosomal storage diseases--the horizon expands.</article-title>
                <source>Nat Rev Neurol.</source>
                <year>2013</year>
                <volume>9</volume>
                <fpage>583</fpage>
                <lpage>98</lpage>
                <pub-id pub-id-type="pmid">23938739</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.boyer.2011.2377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nevo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plaisier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funalot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribouval</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benoit</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Huynh Cong E, Arrondel C, T&#x000ea;te MJ, Montjean R, Richard L, Karras A, Pouteil-Noble C, Balafrej L, Bonnardeaux A, Canaud G, Charasse C, Dantal J, Deschenes G, Deteix P, Dubourg O, Petiot P, Pouthier D, Leguern E, Guiochon-Mantel A, Broutin I, Gubler MC, Saunier S, Ronco P, Vallat JM, Alonso MA, Antignac C, Mollet G. INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy.</article-title>
                <source>N Engl J Med.</source>
                <year>2011</year>
                <volume>365</volume>
                <fpage>2377</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">22187985</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.braulke.2009">
              <mixed-citation publication-type="other">Braulke T, Bonifacino JS. Sorting of lysosomal proteins. Biochim Biophys Acta. 2009;1793:605-14.</mixed-citation>
            </ref>
            <ref id="amrf.REF.brown.2004.2151">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Action myoclonus-renal failure syndrome: the definitive clinico-pathological description.</article-title>
                <source>Brain.</source>
                <year>2004</year>
                <volume>127</volume>
                <fpage>2151</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">15385427</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.burneo.2003.841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Burneo</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnold</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzniecky</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oh</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faught</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Adult-onset neuronal ceroid lipofuscinosis (Kufs disease) with autosomal dominant inheritance in Alabama.</article-title>
                <source>Epilepsia.</source>
                <year>2003</year>
                <volume>44</volume>
                <fpage>841</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12790899</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.cadieuxdion.2013.571">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cadieux-Dion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachance-Touchette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ansorge</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meloche</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barnab&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuzniecky</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faught</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonberg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease.</article-title>
                <source>Clin Genet.</source>
                <year>2013</year>
                <volume>83</volume>
                <fpage>571</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22978711</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.cadieuxdion.2014.470">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cadieux-Dion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turcotte-Gauthier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noreau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meloche</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gravel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Expanding the clinical phenotype associated with ELOVL4 mutation: study of a large French-Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia.</article-title>
                <source>JAMA Neurol.</source>
                <year>2014</year>
                <volume>71</volume>
                <fpage>470</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24566826</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.carpenter.1974.531">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacob</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>Lafora's disease: peroxisomal storage in skeletal muscle.</article-title>
                <source>Neurology.</source>
                <year>1974</year>
                <volume>24</volume>
                <fpage>531</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">4220225</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.carpenter.1981.1564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy.</article-title>
                <source>Neurology.</source>
                <year>1981</year>
                <volume>31</volume>
                <fpage>1564</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6796905</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.chan.2003.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ianzano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munteanu</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christopoulos</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avanzini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jovic</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohlega</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delgado-Escueta</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minassian</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in NHLRC1 cause progressive myoclonus epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>2003</year>
                <volume>35</volume>
                <fpage>125</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12958597</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.chaves.2011.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaves</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beirao</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balreira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaspar</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caiola</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sa-Miranda</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lima</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Progressive myoclonus epilepsy with nephropathy C1q due to SCARB2/LIMP-2 deficiency: clinical report of two siblings.</article-title>
                <source>Seizure.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>738</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21782476</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.coppola.2011.1245">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coppola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santulli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Gaudio</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Natural history and long-term evolution in families with autosomal dominant cortical tremor, myoclonus, and epilepsy.</article-title>
                <source>Epilepsia.</source>
                <year>2011</year>
                <month>Jul</month>
                <volume>52</volume>
                <issue>7</issue>
                <fpage>1245</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">21426326</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.costello.2009.898">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Costello</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiappa</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siao</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Progressive myoclonus epilepsy with demyelinating peripheral neuropathy and preserved intellect: a novel syndrome.</article-title>
                <source>Arch Neurol.</source>
                <year>2009</year>
                <volume>66</volume>
                <fpage>898</fpage>
                <lpage>901</lpage>
                <pub-id pub-id-type="pmid">19597094</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.crompton.2012.474">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crompton</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadleir</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bromhead</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellows</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arsov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harty</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunne</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>Familial adult myoclonic epilepsy: recognition of mild phenotypes and refinement of the 2q locus.</article-title>
                <source>Arch Neurol.</source>
                <year>2012</year>
                <month>Apr</month>
                <volume>69</volume>
                <issue>4</issue>
                <fpage>474</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">22491192</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.dahl.1988.296">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erikson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammarstrom-Heeroma</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pettersson</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Tight linkage between type III Gaucher's disease (Norrbottnian type) and a MspI polymorphism within the gene for human glucocerebrosidase.</article-title>
                <source>Genomics</source>
                <year>1988</year>
                <volume>3</volume>
                <fpage>296</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">2468600</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.depienne.2010.2000">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Depienne</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouteiller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saint-Martin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apartis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labauge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumbach</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>74</volume>
                <fpage>2000</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20548044</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.dibbens.2011.812">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karakis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayly</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costello</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>Mutation of SCARB2 in a patient with progressive myoclonus epilepsy and demyelinating peripheral neuropathy.</article-title>
                <source>Arch Neurol.</source>
                <year>2011</year>
                <volume>68</volume>
                <fpage>812</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21670406</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.dibbens.2009.532">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelucci</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rubboli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayly</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joensuu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassuk</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Power</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassinari</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure.</article-title>
                <source>Ann Neurol.</source>
                <year>2009</year>
                <volume>66</volume>
                <fpage>532</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19847901</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.eskelinen.2003.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eskelinen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>At the acidic edge: emerging functions for lysosomal membrane proteins.</article-title>
                <source>Trends Cell Biol.</source>
                <year>2003</year>
                <volume>13</volume>
                <fpage>137</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">12628346</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.finsterer.2012.316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Finsterer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zarrouk Mahjoub</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Epilepsy in mitochondrial disorders.</article-title>
                <source>Seizure.</source>
                <year>2012</year>
                <volume>21</volume>
                <fpage>316</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">22459315</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.fu.2014.551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aida</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tada</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toyoshima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naito</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onodera</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novel SCARB2 mutations.</article-title>
                <source>Neuropathol Appl Neurobiol.</source>
                <year>2014</year>
                <volume>40</volume>
                <fpage>551</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">23659519</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.gamp.2003.631">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gamp</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lullmann-Rauch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittke</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Hooge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Deyn</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiss</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Illert</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Figura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2003</year>
                <volume>12</volume>
                <fpage>631</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">12620969</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.genton.2013.s8">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasteleijn-Nolst Trenite</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medina</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salas-Puig</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Clinical aspects of juvenile myoclonic epilepsy.</article-title>
                <source>Epilepsy Behav.</source>
                <year>2013</year>
                <volume>28</volume>
                <supplement>Suppl 1</supplement>
                <fpage>S8</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">23756488</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.genton.2010.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>Unverricht-Lundborg disease (EPM1).</article-title>
                <source>Epilepsia.</source>
                <year>2010</year>
                <volume>51</volume>
                <supplement>Suppl 1</supplement>
                <fpage>37</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20331711</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.guerrerol_pez.2012.1826">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrero-L&#x000f3;pez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garc&#x000ed;a-Ruiz</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gir&#x000e1;ldez</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dur&#x000e1;n-Herrera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Querol-Pascual</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ram&#x000ed;rez-Moreno</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e1;s</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serratosa</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure.</article-title>
                <source>Mov Disord.</source>
                <year>2012</year>
                <volume>27</volume>
                <fpage>1826</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23225201</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.guerrini.2001.2459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonanni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrignani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parmeggiani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grosse</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brovedani</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moro</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aridon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrozzo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casari</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2.</article-title>
                <source>Brain.</source>
                <year>2001</year>
                <volume>124</volume>
                <fpage>2459</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">11701600</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.guerrini.1998.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dravet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belmonte</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dulac</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Lamotrigine and seizure aggravation in severe myoclonic epilepsy.</article-title>
                <source>Epilepsia.</source>
                <year>1998</year>
                <volume>39</volume>
                <fpage>508</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9596203</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.hagen.2011.575">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hagen</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murrell</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delisle</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guiot</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghetti</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <article-title>Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene.</article-title>
                <source>Brain Pathol.</source>
                <year>2011</year>
                <volume>21</volume>
                <fpage>575</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">21435071</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.harris.1999.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellodi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Ocular motor abnormalities in Gaucher disease.</article-title>
                <source>Neuropediatrics.</source>
                <year>1999</year>
                <volume>30</volume>
                <fpage>289</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10706022</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.he.2014.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Using a combination of whole-exome sequencing and homozygosity mapping to identify a novel mutation of SCARB2.</article-title>
                <source>Clin Genet.</source>
                <year>2014</year>
                <volume>86</volume>
                <fpage>598</fpage>
                <lpage>600</lpage>
                <pub-id pub-id-type="pmid">24620919</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.higashiyama.2013.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Higashiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakabayashi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurusaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohba</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukai</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyatake</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koyano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuroiwa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N.</given-names>
                  </name>
                </person-group>
                <article-title>A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.</article-title>
                <source>Mov Disord.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>552</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">23325613</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.hopfner.2011.134">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hopfner</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schormair</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knauf</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berthele</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolle</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baron</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treede</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maihofner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunz</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heemann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeufer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaab</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowak</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gieger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lichtner</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trenkwalder</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oexle</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkelmann</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.</article-title>
                <source>BMC Neurol.</source>
                <year>2011</year>
                <volume>11</volume>
                <fpage>134</fpage>
                <pub-id pub-id-type="pmid">22032306</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.ikeda.1990.1561">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ikeda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakigi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Funai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neshige</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuroda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibasaki</surname>
                    <given-names>H.</given-names>
                  </name>
                </person-group>
                <article-title>Cortical tremor: a variant of cortical reflex myoclonus.</article-title>
                <source>Neurology.</source>
                <year>1990</year>
                <volume>40</volume>
                <fpage>1561</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2215948</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.k_lvi_inen.2008.549">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>K&#x000e4;lvi&#x000e4;inen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khyuppenen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koskenkorva</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eriksson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanninen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mervaala</surname>
                    <given-names>E.</given-names>
                  </name>
                </person-group>
                <article-title>Clinical picture of EPM1-Unverricht-Lundborg disease.</article-title>
                <source>Epilepsia.</source>
                <year>2008</year>
                <volume>49</volume>
                <fpage>549</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">18325013</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.klein.2002">
              <mixed-citation publication-type="book">Klein C. Myoclonus and myoclonus-dystonias. In: Pulst S, ed. <italic toggle="yes">Genetics of Movement Disorders</italic>. San Diego, CA: Academic Press; 2002:449-69.</mixed-citation>
            </ref>
            <ref id="amrf.REF.knipper.2006.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knipper</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claussen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruttiger</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lullmann-Rauch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eskelinen</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Deafness in LIMP2-deficient mice due to early loss of the potassium channel KCNQ1/KCNE1 in marginal cells of the stria vascularis.</article-title>
                <source>J Physiol.</source>
                <year>2006</year>
                <volume>576</volume>
                <fpage>73</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">16901941</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.mart_mass_.2013.1399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;-Mass&#x000f3;</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergareche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makarov</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Martinez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorostidi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f3;pez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poza</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buxbaum</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pais&#x000e1;n-Ruiz</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism.</article-title>
                <source>J Mol Med (Berl)</source>
                <year>2013</year>
                <volume>91</volume>
                <fpage>1399</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">23955123</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.minassian.1998.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Minassian</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbrick</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huizenga</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soder</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mungall</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dunham</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fong</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardim</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satishchandra</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snead</surname>
                    <given-names>OC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopes-Cendes</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsui</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delgado-Escueta</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scherer</surname>
                    <given-names>SW</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>1998</year>
                <volume>20</volume>
                <fpage>171</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9771710</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.mink.2013.1101">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mink</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augustine</surname>
                    <given-names>EF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adams</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Classification and natural history of the neuronal ceroid lipofuscinoses.</article-title>
                <source>J Child Neurol.</source>
                <year>2013</year>
                <volume>28</volume>
                <fpage>1101</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">23838030</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.mitchison.1998.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mitchison</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becerra</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munroe</surname>
                    <given-names>PB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lake</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crow</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stephenson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofman</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Philippart</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardiner</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Rawe</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits.</article-title>
                <source>Hum Mol Genet.</source>
                <year>1998</year>
                <volume>7</volume>
                <fpage>291</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9425237</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.muona.2015.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muona</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oliver</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayly</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joensuu</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelucci</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markkinen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heron</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hildebrand</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinuper</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licchetta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Criscuolo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filla</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferlazzo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahmad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baykan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Said</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topcu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riguzzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozkara</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrade</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelsen</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crespel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lindenau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saletti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Privitera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espay</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauffmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duchowny</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000f8;ller</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straussberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Samocha</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrou</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palotie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.</article-title>
                <source>Nat Genet.</source>
                <year>2015</year>
                <volume>47</volume>
                <fpage>39</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">25401298</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.nijssen.2003.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nijssen</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teepen</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyynel&#x000e4;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roos</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant adult neuronal ceroid lipofuscinosis: a novel form of NCL with granular osmiophilic deposits without palmitoyl protein thioesterase 1 deficiency.</article-title>
                <source>Brain Pathol.</source>
                <year>2003</year>
                <volume>13</volume>
                <fpage>574</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">14655761</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.noskov_.2011.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Noskov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Str&#x000e1;neck&#x000fd;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hartmannov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x00159;istoupilov&#x000e1;</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bare&#x00161;ov&#x000e1;</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iv&#x000e1;nek</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x0016f;lkov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jahnov&#x000e1;</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Zee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyynel&#x000e4;</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nijssen</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elleder</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kmoch</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2011</year>
                <volume>89</volume>
                <fpage>241</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">21820099</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.perandones.2012.1200">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Perandones</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Micheli</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellene</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bayly</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                </person-group>
                <article-title>A case of severe hearing loss in action myoclonus renal failure syndrome resulting from mutation in SCARB2.</article-title>
                <source>Mov Disord.</source>
                <year>2012</year>
                <volume>27</volume>
                <fpage>1200</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">22767442</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.perandones.2014">
              <mixed-citation publication-type="other">Perandones C, Pellene LA, Micheli F. Reply: A new SCARB2 mutation in a patient with progressive myoclonus ataxia without renal failure. Mov Disord. 2014.29:158-9.</mixed-citation>
            </ref>
            <ref id="amrf.REF.ramadan.2007.387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramadan</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Din</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ismail</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Twomey</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                </person-group>
                <article-title>Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1.</article-title>
                <source>Neurology</source>
                <year>2007</year>
                <volume>68</volume>
                <fpage>387</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17261688</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.reczek.2007.770">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reczek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jin</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brondyk</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Patten</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edmunds</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.</article-title>
                <source>Cell.</source>
                <year>2007</year>
                <volume>131</volume>
                <fpage>770</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">18022370</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.roze.2008.1010">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apartis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorison</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thobois</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyant-Marechal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranchant</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andr&#x000e9;-Obadia</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maltete</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echaniz-Laguna</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pereon</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaugendre</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Greslan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jedynak</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponsot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dussaule</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations.</article-title>
                <source>Neurology.</source>
                <year>2008</year>
                <volume>70</volume>
                <fpage>1010</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18362280</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.rubboli.2011.2356">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rubboli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambardella</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dibbens</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riguzzi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campieri</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magaudda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassinari</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelucci</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCARB2 mutations.</article-title>
                <source>Epilepsia.</source>
                <year>2011</year>
                <volume>52</volume>
                <fpage>2356</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">22050460</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.schroen.2007.1227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schroen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leenders</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Erk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertrand</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Loon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Leeuwen</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubben</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duisters</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schellings</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssen</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debets</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoydal</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heymans</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>YM</given-names>
                  </name>
                </person-group>
                <article-title>Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy.</article-title>
                <source>J Exp Med.</source>
                <year>2007</year>
                <volume>204</volume>
                <fpage>1227</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">17485520</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.sleat.2009.1708">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sleat</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zheng</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lobel</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Mass spectrometry-based protein profiling to determine the cause of lysosomal storage diseases of unknown etiology.</article-title>
                <source>Mol Cell Proteomics.</source>
                <year>2009</year>
                <volume>8</volume>
                <fpage>1708</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">19383612</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.smith.2013.1417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruni</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giaccone</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossette</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saftig</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gr&#x000f6;tzinger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>NA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Cathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2013</year>
                <volume>22</volume>
                <fpage>1417</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">23297359</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.smith.2012.1102">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franceschetti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canafoglia</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morbin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staropoli</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>WL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahl</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahlo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>Strikingly different clinicopathological phenotypes determined by progranulin mutation dosage.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2012</year>
                <volume>90</volume>
                <fpage>1102</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22608501</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.stogmann.2013.1155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stogmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reinthaler</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eltawil</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Etribi</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hemeda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Nahhas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaber</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fouad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benet-Pages</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eck</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pataraia</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesage</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal recessive cortical myoclonic tremor and epilepsy: association with a mutation in the potassium channel associated gene CNTN2.</article-title>
                <source>Brain.</source>
                <year>2013</year>
                <volume>136</volume>
                <fpage>1155</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">23518707</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.striano.2010.669">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robbiano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Striano</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Familial cortical tremor and epilepsy: a well-defined syndrome with genetic heterogeneity waiting for nosological placement in the ILAE classification.</article-title>
                <source>Epilepsy Behav</source>
                <year>2010</year>
                <volume>19</volume>
                <fpage>669</fpage>
                <pub-id pub-id-type="pmid">20974551</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.takano.1998.1060">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cancel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikeuchi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenzetti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mawad</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevanin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Didierjean</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000fc;rr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oyake</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimohata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koide</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Igarashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishizawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zoghbi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations.</article-title>
                <source>Am J Hum Genet.</source>
                <year>1998</year>
                <volume>63</volume>
                <fpage>1060</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9758625</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.tao.2011.138">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tao</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manak</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowers</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiyonari</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahdaleh</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fox</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gurnett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montine</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaffer</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenfeld</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McConnell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madan-Khetarpal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry-Kravis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griesbach</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saneto</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehaideb</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Shanti</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahajan</surname>
                    <given-names>VB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferguson</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Axelrod</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehesjoki</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fritzsch</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slusarski</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wemmie</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueno</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassuk</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in prickle orthologs cause seizures in flies, mice, and humans.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2011</year>
                <volume>88</volume>
                <fpage>138</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">21276947</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.tsuji.1987.570">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choudary</surname>
                    <given-names>PV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>BM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stubblefield</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayor</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barranger</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginns</surname>
                    <given-names>EI</given-names>
                  </name>
                </person-group>
                <article-title>A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.</article-title>
                <source>New Eng J Med.</source>
                <year>1987</year>
                <volume>316</volume>
                <fpage>570</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">2880291</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.tsuji.2012.587">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Dentatorubral-pallidoluysian atrophy.</article-title>
                <source>Handb Clin Neurol.</source>
                <year>2012</year>
                <volume>103</volume>
                <fpage>587</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">21827919</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.vadlamudi.2006.1310">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vadlamudi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vears</surname>
                    <given-names>DF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedagogus</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                </person-group>
                <article-title>Action myoclonus-renal failure syndrome: a cause for worsening tremor in young adults.</article-title>
                <source>Neurology.</source>
                <year>2006</year>
                <volume>67</volume>
                <fpage>1310</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">17030781</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.van_diggelen.2001.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Diggelen</surname>
                    <given-names>OP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thobois</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tilikete</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabot</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keulemans</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bunderen</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taschner</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Losekoot</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voznyi</surname>
                    <given-names>YV</given-names>
                  </name>
                </person-group>
                <article-title>Adult neuronal ceroid lipofusciosis with palmitoyl-proteinthioesterase deficiency: first adultt-onset patients of a childhood disease.</article-title>
                <source>Ann Neurol.</source>
                <year>2001</year>
                <volume>50</volume>
                <fpage>269</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11506414</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.velayati.2011.1232">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Velayati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DePaolo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moaven</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westbroek</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goker-Alpan</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stubblefield</surname>
                    <given-names>BK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodny</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tayebi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sidransky</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A mutation in SCARB2 is a modifier in Gaucher disease.</article-title>
                <source>Hum Mutat.</source>
                <year>2011</year>
                <volume>32</volume>
                <fpage>1232</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21796727</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.xin.2010.565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xin</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>TE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kiely</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Min</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Malley</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu-Shore</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mole</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goebel</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sims</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>74</volume>
                <fpage>565</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">20157158</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.yamayoshi.2012a.32">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamayoshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Scavenger receptor b2 as a receptor for hand, foot, and mouth disease and severe neurological diseases.</article-title>
                <source>Front Microbiol.</source>
                <year>2012a</year>
                <volume>3</volume>
                <fpage>32</fpage>
                <pub-id pub-id-type="pmid">22363322</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.yamayoshi.2012b.5686">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamayoshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iizuka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minagawa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizuta</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanjoh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katsushima</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Itagaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71.</article-title>
                <source>J Virol.</source>
                <year>2012b</year>
                <volume>86</volume>
                <fpage>5686</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">22438546</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.yamayoshi.2013.3335">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamayoshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71.</article-title>
                <source>J Virol.</source>
                <year>2013</year>
                <volume>87</volume>
                <fpage>3335</fpage>
                <lpage>47</lpage>
                <pub-id pub-id-type="pmid">23302872</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.yamayoshi.2009.798">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yamayoshi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamashita</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanagata</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minowa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takemura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koike</surname>
                    <given-names>S.</given-names>
                  </name>
                </person-group>
                <article-title>Scavenger receptor B2 is a cellular receptor for enterovirus 71.</article-title>
                <source>Nat Med.</source>
                <year>2009</year>
                <volume>15</volume>
                <fpage>798</fpage>
                <lpage>801</lpage>
                <pub-id pub-id-type="pmid">19543282</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.zeigler.2014.210">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zeigler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meiner</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner-Birmanns</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bargal</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sury</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mengistu</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakhlon</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leykin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramsky</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lossos</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced beta-glucocerebrosidase activity.</article-title>
                <source>J Neurol Sci.</source>
                <year>2014</year>
                <volume>339</volume>
                <fpage>210</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">24485911</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.zifkin.2005.147">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zifkin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <article-title>Mechanisms, genetics, and pathogenesis of juvenile myoclonic epilepsy.</article-title>
                <source>Curr Opin Neurol.</source>
                <year>2005</year>
                <volume>18</volume>
                <fpage>147</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">15791145</pub-id>
              </element-citation>
            </ref>
            <ref id="amrf.REF.zimprich.2001.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asmus</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naumann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertram</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheidtmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kern</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkelmann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Myhsok</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riedel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meitinger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strom</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome.</article-title>
                <source>Nat Genet.</source>
                <year>2001</year>
                <volume>29</volume>
                <fpage>66</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11528394</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="amrf.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="amrf.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>17 December 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>25 February 2014 (da) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
